IONS

Technically, Ionis Pharmaceuticals scores 5.77/10 with a neutral rating. Bullish signals like MACD Golden Cross and Marubozu White are offset by bearish patterns such as Bearish Engulfing. Recent indicator history shows mixed win rates and modest returns, suggesting the stock is in a volatile phase without a clear directional bias. Traders should monitor short-term price action closely and avoid over-exposure until a clearer trend emerges.